|
DNTTIP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10862446895044E-15 |
| Normal-vs-Stage2 |
9.52069978410464E-10 |
| Normal-vs-Stage3 |
4.2899017671516E-13 |
| Normal-vs-Stage4 |
2.36477504245158E-14 |
| Stage1-vs-Stage2 |
3.942600E-01 |
| Stage1-vs-Stage3 |
3.102600E-01 |
| Stage1-vs-Stage4 |
3.480600E-03 |
| Stage2-vs-Stage3 |
9.303800E-01 |
| Stage2-vs-Stage4 |
2.416600E-01 |
| Stage3-vs-Stage4 |
1.134950E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.208760E-04 |
| Normal-vs-Asian |
6.44030051510924E-10 |
| Caucasian-vs-AfricanAmerican |
2.471200E-01 |
| Caucasian-vs-Asian |
8.422400E-01 |
| AfricanAmerican-vs-Asian |
2.468600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.17363929475323E-14 |
| Normal-vs-Female |
1.62414526272414E-12 |
| Male-vs-Female |
7.720800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.25963692201958E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
1.66422431391311E-12 |
| Normal-vs-Age(81-100Yrs) |
1.248440E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.454100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.768200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.629000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.946600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.605600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.034600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.526300E-02 |
| Classical-VS-Follicular |
8.519300E-03 |
| Classical-VS-Other |
9.393700E-02 |
| Classical-VS-Normal |
9.33980004447221E-10 |
| Tall-VS-Follicular |
9.734000E-01 |
| Tall-VS-Other |
4.857000E-01 |
| Tall-VS-Normal |
6.80080436410435E-11 |
| Follicular-VS-Other |
5.739000E-01 |
| Follicular-VS-Normal |
2.28161933790716E-12 |
| Other-VS-Normal |
1.608190E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
2.76778600039052E-13 |
| N0-vs-N1 |
1.480970E-01 |
|
|
